Search alternatives:
significantly related » significantly correlated (Expand Search), significantly elevated (Expand Search), significantly reduced (Expand Search)
significantly small » significantly smaller (Expand Search), significantly impact (Expand Search), significantly impair (Expand Search)
related decrease » reported decrease (Expand Search), related disease (Expand Search), greater decrease (Expand Search)
small decrease » small increased (Expand Search)
significantly related » significantly correlated (Expand Search), significantly elevated (Expand Search), significantly reduced (Expand Search)
significantly small » significantly smaller (Expand Search), significantly impact (Expand Search), significantly impair (Expand Search)
related decrease » reported decrease (Expand Search), related disease (Expand Search), greater decrease (Expand Search)
small decrease » small increased (Expand Search)
-
1481
-
1482
Patient demographics by BMI missingness in the United Kingdom NJR data and Danish data.
Published 2025Subjects: -
1483
PGAM5 knockdown prevented rTsSPc from disrupting Caco-2 monolayer integrity.
Published 2025Subjects: -
1484
Inhibition of PGAM5 and apoptosis alleviated the rTsSPc-damaged Caco-2 monolayer barrier integrity.
Published 2025Subjects: -
1485
-
1486
Apoptosis inhibitor abolished and restored rTsSPc-disrupted Caco-2 monolayer barrier integrity.
Published 2025Subjects: -
1487
rTsSPc interacted with PGAM5 and increased its protein expression in Caco-2 cells.
Published 2025Subjects: -
1488
-
1489
Inhibition of PGAM5 and apoptosis prevented <i>T. spiralis</i> larval invasion of Caco-2 monolayer.
Published 2025Subjects: -
1490
Supplementary Material for: Supportive care for common conditions in small vulnerable newborns and term infants: the evidence
Published 2025“…Introduction Small vulnerable newborns (SVN) are at an increased risk of early death and other morbidities. …”
-
1491
-
1492
-
1493
-
1494
Table 4_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.xlsx
Published 2025“…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
-
1495
Table 2_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.xlsx
Published 2025“…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
-
1496
Table 1_Repurposing of the small-molecule adrenoreceptor-inhibitor carvedilol for treatment of the fibrotic lung.xlsx
Published 2025“…</p>Methods<p>In silico modeling of dysregulated pathways in IPF and screening for putative interfering small molecules identified carvedilol as a promising anti-fibrotic agent. …”
-
1497
Table 1_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.docx
Published 2025“…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
-
1498
Table 3_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.xlsx
Published 2025“…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
-
1499
Image 3_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.tif
Published 2025“…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”
-
1500
Image 1_Scalability of spheroid-derived small extracellular vesicles production in stirred systems.tif
Published 2025“…Introduction<p>Small extracellular vesicle (sEV)-based therapies have gained widespread interest, but challenges persist to ensure standardization and high-scale production. …”